MedPath

Effects of Albendazole in HIV patients who are not on ART

Phase 3
Completed
Conditions
Health Condition 1: null- HIV positive ART naive
Registration Number
CTRI/2018/05/014237
Lead Sponsor
AFMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

HIV positive adults more than 18yrs of age

HIV positive patients not on ART

HIV positive patients not meeting WHO clinical criteria for initiation of ART

CD4 count >500/mm3 at baseline

Exclusion Criteria

Patients who have opportunistic infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath